Tradestie Institutional Equity Comparison Engine
NVS vs MRK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NVS Overall Edge
NVS Captures Institutional Edge (3โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Options & Structure while MRK counters with relative strength in Momentum & Technical. Fundamentally, NVS trades at 16.2x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus MRK at 16.4x Forward P/E and 35.2% operating margin (+4.7% YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against MRK sits in CONSOLIDATION (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NVS
NVS 16.2x vs MRK 16.4x Fwd P/E
Growth & Margin Winner
NVS
Op Margin 34.0% vs 35.2% ยท YoY +4.7% vs +4.7%
Momentum & Technical Winner
MRK
1Y +22.5% vs +57.5% ยท 52W Pos 81% vs 84%
Options & Structure Winner
NVS
UNCLASSIFIED (6th %ile IV) vs CONSOLIDATION (100th %ile IV)
NVS
NYSE
Novartis AG
Pharmaceutical Preparations
$161.59
+0.68% 1D
Market Cap
$302.9B
1M Return
+7.28%
1Y Return
+22.5%
Forward P/E
16.2x
Unified AI Score
41.5 / 100
SELL
Tech 29.0
Fund 38.0
Flow 50.0
Mom 21.1
MRK
NYSE
Merck & Co., Inc.
Pharmaceutical Preparations
$146.35
-0.95% 1D
Market Cap
$362.3B
1M Return
+0.27%
1Y Return
+57.48%
Forward P/E
16.4x
Unified AI Score
57.1 / 100
HOLD
Tech 48.0
Fund 65.0
Flow 67.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NVS +22.5%
MRK +57.48%
Spread: +34.98 pp (MRK Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NVS TTM Op. Margin: 34.0%
MRK TTM Op. Margin: 35.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs MRK. Trailing 12-month operating profitability (NVS 34.0% vs MRK 35.2%) and valuation multiples (NVS 16.2x vs MRK 16.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NVS | MRK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $302.9B | $362.3B | Larger Scale | MRK |
| Trailing P/E Ratio Valuation | 30.6x | 148.4x | Lower Multiple | NVS |
| Forward P/E Ratio Valuation | 16.2x | 16.4x | Lower Multiple | NVS |
| Revenue Growth (YoY) Growth | +4.7% | +4.7% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 34.0% | 35.2% | Higher Margin | MRK |
| Net Profit Margin Profitability | 17.5% | 3.6% | Higher Margin | NVS |
| Return on Equity (ROE) Capital Efficiency | 24.3% | 5.1% | Higher ROE | NVS |
| 52-Week Range Position Momentum | 81% ($123โ$170) | 84% ($91โ$157) | Stronger Trend | MRK |
| Beta / 30D Volatility Risk Regime | 0.31ฮฒ ยท 27% Vol | 0.19ฮฒ ยท 31% Vol | Lower Realized Risk | NVS |
| Unified Institutional Score Composite Signal | 41.5 / 100 (SELL) | 57.1 / 100 (HOLD) | Higher Composite | MRK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NVS vs MRK Buy Guide
NVS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
MRK
CONSOLIDATION
57d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NVS nor MRK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.